cs.CVNov 14, 2026

Where slide-level foundation-model classifiers fail on atypical breast lesions

Authors: Nerea Hernandez, Luis J. Herrera, Cesar Ramirez, Olga Valenzuela, Ignacio Rojas, Francisco M. Ortuño

Organizations: Department of Computer Engineering, Automation and Robotics, CITIC-UGR, University of Granada, Granada, 18071, Spain · Hospital Universitario Clínico San Cecilio, Granada, 18016, Spain · Department of Applied Mathematics, University of Granada, Granada, 18071, Spain

Abstract

Whether a ductal breast lesion is called atypical hyperplasia or low-grade carcinoma in situ increasingly determines surgery. However, slide-level classifiers built on pathology foundation models (PFMs) perform worst on these lesions. Using four PFMs, cross-validation on BRACS and preregistered hypotheses, we studied where the classification of atypia fails. Because slides are labelled with their most severe lesion, only 39% of the slides with annotated atypical ductal hyperplasia (ADH) were labelled ADH. Attention ranked the lesion high but rarely first, and showing the model only the lesion helped little, whereas classifiers trained per decision with lesion-level labels improved all four atypical boundaries. ADH regions inserted into benign slides raised the probability of malignancy more than that of atypia. In a hospital with pathologist-labelled single-subtype slides and in HISTAI, benign slides were scored closer to lesions and triage specificity fell from 0.48-0.53 to 0.00-0.07 and 0.22.

Figures & tables

Explore similar work

Sep 20, 2026

WILSON - Multi-magnification composites as a foundation for patient-level pathology analysis and diagnostic text generation

Pathologists examine tissue sections across multiple magnifications and slides, integrating morphological information to establish a diagnosis. In contrast, most pathology foundation models encode thousands of image patches from a single representative ("best") slide and aggregate their features, limiting multiscale and patient-level contextual integration. Here we introduce WILSON, a vision-language foundation model that represents whole-slide images and multi-slide cases through multi-magnification composites. Trained on approximately 189,000 slides spanning 42 organs and 838 diagnostic entities, WILSON enables patient-level analysis, multimodal retrieval and diagnostic text generation. Without task-specific training, WILSON outperformed a dedicated case-level model (macro-F1, 0.52 versus 0.38) and matched substantially larger slide-level models while requiring 400-1,350 times fewer computational operations. End-to-end fine-tuning improved breast cancer subtyping and stromal lymphocyte grading. WILSON also surpassed PRISM in image-text retrieval (recall@1, 75.6% versus 58.1%) and generated diagnostic descriptions that received higher ratings from five board-certified pathologists than competing models. These findings demonstrate that compact, multiscale representations can support computationally efficient, clinically grounded pathology foundation models.
Mar 3, 2026

BRIGHT: A Collaborative Generalist-Specialist Foundation Model for Breast Pathology

Generalist pathology foundation models (PFMs), pretrained on large-scale multi-organ datasets, have demonstrated remarkable predictive capabilities across diverse clinical applications. However, their proficiency on the full spectrum of clinically essential tasks within a specific organ system remains an open question due to the lack of large-scale validation cohorts for a single organ as well as the absence of a tailored training paradigm that can effectively translate broad histomorphological knowledge into the organ-specific expertise required for specialist-level interpretation. In this study, we propose BRIGHT, the first PFM specifically designed for breast pathology, trained on over 51,000 breast whole-slide images derived from a cohort of over 40,000 patients across 19 hospitals. BRIGHT employs a collaborative generalist-specialist framework to capture both universal and organ-specific features. To comprehensively evaluate the performance of PFMs on breast oncology, we curate the largest multi-institutional cohorts to date for downstream task development and evaluation, comprising over 25,000 WSIs across 10 hospitals. The validation cohorts cover the full spectrum of breast pathology across 25 distinct clinical tasks spanning diagnosis, biomarker prediction, treatment response and survival prediction. Extensive experiments demonstrate that BRIGHT outperforms five leading generalist PFMs, achieving state-of-the-art (SOTA) performance in 25 of 25 internal validation tasks and in 4 of 11 external validation tasks with excellent heatmap interpretability. By evaluating on large-scale validation cohorts, this study not only demonstrates BRIGHT's clinical utility in breast oncology but also validates a collaborative generalist-specialist paradigm, providing a scalable template for developing PFMs on a specific organ system, accelerating the translation of foundation models into ...
Apr 21, 2026

Unified Multi-Foundation-Model Slide Representation for Pan-Cancer Recognition and Text-Guided Tumor Localization

The expanding ecosystem of pathology foundation models has produced powerful but fragmented tile-level representations, limiting their use in clinical tasks that require unified slide-level reasoning and interpretable linkage to clinically meaningful information. We present ASTRA, a pan-cancer framework that integrates heterogeneous foundation-model representations into a shared slide-level representation space and semantically grounds that space using structured pathology annotation fields, including classification category, cancer type, and anatomic site. ASTRA combines sparse mixture-of-experts contextualization, masked multi-model reconstruction, and contrastive alignment to structured pathology prompts to learn slide representations that support 4-category classification, 3-class solid tumor typing, 16-class cancer typing, and text-guided tumor localization without pixel-level supervision. Developed on a CHTN cohort of 10,359 whole-slide images (WSIs) spanning 16 tumor types, ASTRA consistently improves pan-cancer classification across four pathology foundation-model backbones, achieving up to 97.8% macro-AUC for 4-category classification, 99.7% for 3-class solid tumor typing, and 99.2% for 16-class cancer typing. For tumor localization, ASTRA achieves a mean Dice of 0.897 on an annotated in-domain CHTN subset (n = 380) spanning 16 cancer types and 0.738 on an external TCGA cohort (n = 1,686) spanning four cancer types. These results demonstrate that minimal structured pathology annotation fields derived from slide-level metadata can provide effective semantic supervision for unified slide representation learning, enabling both pan-cancer prediction and weakly supervised tumor localization within a single framework.